| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |